Pasar al contenido principal

NUEVAS DIANAS TERAPEUTICAS METABOLICAS EN AORTOPATIAS

PID2022-137730OA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUTO DE INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Defective Mitochondrial Respiration in Hereditary Thoracic Aneurysms

  • Marcos-Ríos, Daniel
  • Rochano-Ortiz, Antonio
  • Méndez-Barbero, Nerea
  • Oller, Jorge
This article belongs to the Special Issue Molecular and Cellular Mechanisms of Marfan Syndrome., Thoracic aortic aneurysms are life-threatening vascular conditions linked to inherited disorders such as Marfan syndrome, Loeys–Dietz syndrome, vascular Ehlers–Danlos syndrome, and familial thoracic aortic aneurysms and dissections. While traditionally associated with the extracellular matrix and contractile defects in vascular smooth muscle cells, emerging evidence suggests the key role of mitochondrial dysfunction. Here, we show that the overexpression of ACTA2R179H and TGFBR2G357W in murine aortic VSMCs reduces Mitochondrial Transcription Factor A (Tfam) expression, decreases mitochondrial DNA (mtDNA) content, and impairs oxidative phosphorylation, shifting metabolism toward glycolysis. Notably, nicotinamide riboside, a NAD+ precursor, restores mitochondrial respiration, increases Tfam and mtDNA levels, and promotes a contractile phenotype by enhancing actin polymerization and reducing matrix metalloproteinase activity. These findings identify mitochondrial dysfunction as a shared feature in hereditary thoracic aortic aneurysm, not only in Marfan syndrome, but also in other genetic forms, and highlight mitochondrial boosters as a potential therapeutic strategy., A.R.-O. is supported by the Conchita-Rábago Foundation 2024 grant. N.M.-B. is supported by Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (ISCiii/FEDER, PI21/01126 and PI24/00180, CP19/00151 Miguel Servet contract), Sociedad Española de Arteriosclerosis, and CIBERCV, Spain. J.O. is supported by a Ramón y Cajal contract (RYC2021-033343-I), and grant from Spanish Science Ministry (PID2022-137730OA-I00/ AEI/10.13039/501100011033/ FEDER, UE) and Marfan Spanish association (SIMA, www.Marfan.es)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Excessive glycosylation drives thoracic aortic aneurysm formation through integrated stress response

  • Rochano-Ortiz, Antonio
  • Simó, Carolina
  • García-Cañas, Virginia
  • Gabandé-Rodríguez, Enrique
  • Mittelbrunn, María
  • Oller, Jorge
Rochano-Ortiz et al., [Background and aims]: Thoracic aortic aneurysms and dissections (TAADs) are depicted by aortic medial degeneration characterized by glycan-rich matrix accumulation. Marfan syndrome (MFS) is the most common inherited connective tissue disorder associated with TAAD. Although vascular smooth muscle cell metabolic dysfunction has emerged as a pathogenic driver of TAAD, surgical repair remains the mainstay of treatment. This study aimed to investigate the role of the hexosamine biosynthetic pathway (HBP) in sporadic and genetic TAAD pathophysiology., [Methods]: Hexosamine biosynthetic pathway activation was analysed in aortas from an MFS mouse model, a β-aminopropionitrile-induced non-genetic TAAD model, and patients with sporadic TAAD using transcriptomic and metabolomic approaches. Aortic dilatation was monitored by ultrasound imaging. Pharmacological inhibition of HBP and integrated stress response (ISR) was performed to assess their therapeutic potential., [Results]: Hexosamine biosynthetic pathway was up-regulated in both an MFS mouse model and β-aminopropionitrile-induced TAAD, as well as in aortic samples from MFS and sporadic TAAD patients. Enhanced HBP activity contributed to aortic dilatation and medial degeneration via vascular smooth muscle cell dysfunction and ISR activation. Inhibition of HBP or ISR reversed these effects in the MFS model., [Conclusions]: The HBP-ISR axis drives medial degeneration in TAAD. These findings identify HBP and ISR as a potential target in TAAD of both genetic and non-genetic origin., A.R.-O. is supported by the Conchita-Rábago Foundation 2024 grant. J.O. is supported by a Ramón y Cajal contract (RYC2021-033343-I) and grant from Spanish Ministerio de Ciencia e Innovación grant (PID2022-137730OA-I00) funded by MCIN/AEI/10.13039/501100011033/FEDER, EU; granted by Fundación MERCK-FEDER ‘Investigación clínica en enfermedades raras 2022’, Marfan Spanish Association (SIMA, www.Marfan.es) and by ‘V-Ayudas Muévete por los que no pueden 2021’. Research in M.M.’s lab was supported by European Research Council grant ERC-2021-CoG 101044248-LetTBe and the Y2020/BIO-6350 NutriSION-CM synergy grant from Comunidad de Madrid, Ministerio de Ciencia e Innovacion, Spain (grants PID2022-141169OB-I00 and PID2022-138295OB-I00). European Research Council. M.M.-L., G.A.-L., and G.A.-E. are funded by Instituto de Salud Carlos III through the projects PI20/01103, PI23/00100, and CP22/00100 (co-funded by European Regional Development Fund/European Social Fund ‘A way to make Europe’/‘Investing in your future’). J.L.M.-V. is supported by grant from Spanish Ministerio de Ciencia e Innovación (PID2022-136979OB-I00). L.M.B.-C. is supported by Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III (ISCIII/FEDER PI22/00233). G.T.-T. and A.G. are supported by Spanish Society of Cardiology (SEC/FEC-INV-CLI 20/015). O.L. is supported by grant from Spanish Health Ministry or Spanish Ministerio de Sanidad (PI20/00923 Instituto Carlos III). J.F.N. is supported by grant from Spanish Health Ministry or Spanish Ministerio de Sanidad (PI21/00084 FIS) and a grant from Health Research Institute Valdecilla (INNVAL21/24). N.M-B. is supported by Spanish Health Ministry or Spanish Ministeiro de Sanidad (PI21/01126). M.J.F.-G. is supported by Spanish Health Ministry or Spanish Ministerio de Sanidad contract (FIS22/00140). J.M.R. has received funding from La Caixa Foundation (HR18-00068); Spanish Ministerio de Ciencia e Innovación grant PID2021-122388OB-100 funded by MCIN/AEI/10.13039/501100011033; and Instituto de Salud Carlos III (CIBER-CV CB16/11/00264); Fundació La Marató TV3 grant 202334-31, and Spanish Ministerio de Ciencia e Innovación contract FPI (BES-2016-077649) to M.J.R.-R. The CBMSO is supported by Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid. CBMSO is a Severo Ochoa Centers of Excellence (grant CEX2021-001154-S) funded by MICIN/AEI/10.13039/501100011033., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2021-001154-S)., Peer reviewed